Christian Jorgensen, M.D., Ph.D.


Prof. Christian Jorgensen specializes in Therapeutics and Rheumatology, he is the director of the IRMB, leader of the ‘Mesenchymal stem Cells, niche tissue and homeostasis’ research team and coordinator of the ECellFrance, a national infrastructure dedicated to stem cell therapy, and Cartigen platforms at Montpellier CHRU. He is an expert for Biologics at French National Authority or Health (HAS), and a former member of the Transparency Comity at HAS.

Pr. Jorgensen clinical interest are in stem cells, immunology and rheumatology. He leads the clinical immunology service dedicated to biotherapy applied to Rheumatoid Arthritis and other autoimmune diseases. C. Jorgensen has published extensively (over 250 publications in the field of Immunology and stem cell therapy applied for rheumatic diseases), and has coordinated several national and European programs on immunology, including Genostem: Adult mesenchymal stem cells engineering for connective tissue disorders; ADIPOA project, a large scale project focusing on adipose-derived mesenchymal stem cells in osteoarthritis therapy, and the RESPINE project focusing on degenerative disc disease treatment using stem cells.

Christian Jorgensen, M.D., Ph.D.

Professor and Director of the Institute for Regenerative Medicine and Biotherapy (IRMB), INSERM U1183, Saint Eloi Hospital, CHRU Montpellier France.


Doctor of Philosophy, University Paris, 1991

Doctor of Medicine, University Paris, 1991